title: Acute iris depigmentation following systemic moxifloxacin.
authors.forename: Heloisa Moraes do
authors.initials: HM
authors.lastname: Nascimento
authors.forename: Jacqueline Martins de
authors.initials: JM
authors.lastname: Sousa
authors.forename: Mauro Silveira de Queiroz
authors.initials: MS
authors.lastname: Campos
authors.forename: Rubens
authors.initials: R
authors.lastname: Belfort
mesh_terms: D000208:Acute Disease; D000328:Adult; D000368:Aged; D000900:Anti-Bacterial Agents / Q000009:adverse effects*; D001372:Aza Compounds / Q000009:adverse effects*; D005260:Female; D024841:Fluoroquinolones; D006801:Humans; D007499:Iris Diseases / Q000139:chemically induced* / Q000175:diagnosis; D008297:Male; D000077266:Moxifloxacin; D010859:Pigmentation Disorders / Q000139:chemically induced* / Q000175:diagnosis; D011804:Quinolines / Q000009:adverse effects*
chemical_list: D000900:Anti-Bacterial Agents; D001372:Aza Compounds; D024841:Fluoroquinolones; D011804:Quinolines; D000077266:Moxifloxacin
references.citation: Ophthalmology. 2009 Aug;116(8):1552-7, 1557.e1
references.pmid: 19545903
references.citation: Arch Ophthalmol. 2011 Oct;129(10):1312-9
references.pmid: 21987674
references.citation: J Med Pharm Chem. 1962 Sep;91:1063-5
references.pmid: 14056431
references.citation: Eye (Lond). 2009 Dec;23(12):2260-2
references.pmid: 19851342
references.citation: Arch Soc Esp Oftalmol. 2004 Jul;79(7):357-9
references.pmid: 15286907
references.citation: Ocul Immunol Inflamm. 2012 Aug;20(4):266-72
references.pmid: 22694259
references.citation: J Ophthalmic Inflamm Infect. 2013 Jan 14;3(1):10
references.pmid: 23514193
references.citation: J Ocul Pharmacol Ther. 2012 Jun;28(3):278-82
references.pmid: 22304496